Table 5.
Comparison of the 24-hour survival and nonsurvival groups in all patients (n = 29).
| 24-hour survival group (n = 7) | Nonsurvival group (n = 22) | p value | |
|---|---|---|---|
| Sex (male/female) | 6/1 | 11/11 | 0.1872 |
| Age (y) | 85 (52–87) | 78 (41–93) | 0.6134 |
| Temperature (°C) | 35.0 (34.3–38.4) | 34.8 (32.0–38.0) | 0.1900 |
| Arterial blood gas (pH) | 6.912 (6.685–7.090) | 6.903 (6.415–7.418) | 0.8496 |
| Arterial blood PO2 (mmHg) | 85.1 (42.9–157) | 83.6 (33.8–167) | 0.5703 |
| Arterial blood PCO2 (mmHg) | 72.3 (27.2–179) | 40.2 (9.1–337) | 0.8336 |
| Arterial blood bicarbonate (mEq/L) | 18.4 (12.7–23.4) | 17.8 (8.4–36.5) | 0.8749 |
| Lactic acid (mEq/L) | 12.6 (8.92–14.2) | 11.4 (1.67–23.4) | 0.7687 |
| Na (mEq/L) | 140 (135–146) | 143 (134–164) | 0.4347 |
| K (mEq/L) | 4.3 (3.3–6.0) | 6.8 (3.7–13) | 0.0004∗ |
| White blood cell count (/μL) | 10500 (8200–17000) | 13500 (3800–17800) | 0.4595 |
| Blood glucose (mg/dL) | 374 (243–554) | 171 (23–671) | 0.0312∗ |
| TSH (μIU/mL) | 1.950 (0.306–5.160) | 2.882 (0.260–45.89) | 0.2233 |
| F-T3 (pg/mL) | 2.56 (2.10–3.56) | 2.45 (1.60–4.64) | 0.6990 |
| F-T4 (ng/dL) | 1.03 (0.90–1.43) | 0.95 (0.56–1.63) | 0.1663 |
| ACTH (pg/mL) | 28.3 (3.2–269) | 23.2 (2.7–152) | 0.4574 |
| Cortisol (μg/dL) | 9.0 (4.3–30.2) | 21.2 (2.5–74.1) | 0.0546 |
| GH (ng/mL) | 2.41 (1.51–7.74) | 4.79 (0.16–24.5) | 0.1143 |
| IGF-1 (ng/mL) | 90.3 (32.0–146) | 62.0 (8.4–188) | 0.2927 |
| Aldosterone (pg/mL) | 162 (49.3–223) | 152 (49.6–3038) | 0.2237 |
| PRA (ng/mL/h) | 3.5 (1.1–6.0) | 2.3 (0.3–69) | 0.1157 |
Data are shown as medians (range), except sex. p values were determined by logistic regression analysis, except for sex (chi-squared test). ∗p < 0.05. ROSC, return of spontaneous circulation; Na, sodium; K, potassium; TSH, thyroid stimulating hormone; F-T3, free T3; F-T4, free T4; ACTH, adrenocorticotrophic hormone; GH, growth hormone; IGF-1, insulin-like growth factor-1; PRA, plasma renin activity.